Nerelimomab Reduces Capsaicin-Induced Lung Injury
Author Information
Author(s): Huang Lijuan, Du Bing, Cui Xiaohu, Zhao Hanqing, Feng Yanlin, Xu Ziying, Long Jianhai, Yuan Jing, You Fuping, Koga Yoshikatsu, Xi Jinxiang
Primary Institution: Peking University Health Science Center
Hypothesis
This study investigates the role of TNF signaling in capsaicin-induced acute lung injury and the therapeutic potential of Nerelimomab.
Conclusion
Nerelimomab effectively alleviates acute lung injury caused by capsaicin by inhibiting TNF signaling and reducing apoptosis.
Supporting Evidence
- Nerelimomab treatment reduced the number of apoptotic cells.
- IL-6 and IL-18 levels were significantly elevated in capsaicin-treated groups.
- Nerelimomab improved survival rates in treated mice.
- Transcriptomic and proteomic analyses confirmed the role of TNF signaling in lung injury.
- Nerelimomab increased the Bcl-2/Bax ratio and decreased cleaved caspase 3 expression.
Takeaway
Capsaicin can hurt your lungs, but a medicine called Nerelimomab can help fix that damage.
Methodology
The study used transcriptomic and proteomic analyses on mouse lung tissue and assessed the effects of Nerelimomab in vivo and in vitro.
Limitations
The study primarily focused on a specific mouse model and may not fully represent human responses.
Participant Demographics
C57BL/6N mice were used in the study.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website